SuperworthENDRA Life Sciences market cap NDRA
Share price times shares outstanding: what the whole company sells for, since 2017.
- Today, Oct 23, 2026
- $7.2M
- Highest close in our data
- $114M
- Apr 2021
ENDRA Life Sciences is worth $7.2M at the close on Oct 23, 2026, at $4.80 a share.
That is up 91% over the last year and down 89% over five years.
Its highest close in our data was $114M in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $7.2M | $3.9M | $9.1M | +21% |
| 2025 | $5.9M | $1.8M | $7M | +75% |
| 2024 | $3.4M | $187.9K | $10.9M | −79% |
| 2023 | $15.9M | $4.4M | $18.7M | +23% |
| 2022 | $12.9M | $10.1M | $30.1M | −56% |
| 2021 | $29.2M | $23.1M | $114M | +55% |
| 2020 | $18.8M | $6.6M | $21.8M | +82% |
| 2019 | $10.4M | $5.2M | $23.8M | +7% |
| 2018 | $9.7M | $6.8M | $24.3M | −49% |
| 2017 | $19M | $8.6M | $19M | n/a |
Against its peers
Companies in Healthcare nearest ENDRA Life Sciences' size, closest first, today.
| Company | Market cap |
|---|---|
| NDRAENDRA Life Sciences | $7.2M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $52.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on ENDRA Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.